CRIS Current Research Information System

DE ROSA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.937
AS - Asia 1.515
EU - Europa 1.366
AF - Africa 95
SA - Sud America 87
Continente sconosciuto - Info sul continente non disponibili 85
OC - Oceania 5
Totale 5.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.892
VN - Vietnam 492
SG - Singapore 387
CN - Cina 360
IT - Italia 356
GB - Regno Unito 285
SE - Svezia 147
DE - Germania 127
FR - Francia 86
IN - India 79
HK - Hong Kong 67
RU - Federazione Russa 63
IE - Irlanda 58
BR - Brasile 57
CH - Svizzera 53
NL - Olanda 44
JP - Giappone 39
ZA - Sudafrica 35
FI - Finlandia 33
UA - Ucraina 30
TG - Togo 29
CA - Canada 18
EE - Estonia 18
BG - Bulgaria 17
JO - Giordania 16
PH - Filippine 14
BE - Belgio 13
AR - Argentina 10
KR - Corea 9
TH - Thailandia 9
MX - Messico 8
PL - Polonia 8
SC - Seychelles 8
AT - Austria 7
CI - Costa d'Avorio 6
CR - Costa Rica 6
IQ - Iraq 6
IR - Iran 6
NG - Nigeria 6
TW - Taiwan 6
VE - Venezuela 6
AU - Australia 5
BD - Bangladesh 5
CL - Cile 5
ID - Indonesia 5
CO - Colombia 4
ES - Italia 4
NI - Nicaragua 4
RO - Romania 4
GR - Grecia 3
MY - Malesia 3
PK - Pakistan 3
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
PA - Panama 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
DM - Dominica 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TR - Turchia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.005
Salva come PNG Salva come JPEG
Città #
Singapore 269
Southend 260
Ashburn 200
Chandler 188
Dong Ket 162
Santa Clara 122
San Jose 108
Ho Chi Minh City 99
Fairfield 95
Hanoi 81
Princeton 72
Wilmington 65
Hong Kong 62
New York 61
Dublin 58
Houston 55
Council Bluffs 53
Beijing 52
Bern 49
Ann Arbor 45
Bologna 42
Woodbridge 41
Boardman 36
Tokyo 35
Seattle 34
Rome 31
Helsinki 29
Lauterbourg 29
Lomé 29
Los Angeles 29
Nanjing 28
Westminster 28
Padova 27
Cambridge 26
Milan 25
Jinan 23
Medford 23
Dallas 21
Shenyang 18
Sofia 17
Saint Petersburg 16
Amman 15
Mülheim 14
Turin 14
Berlin 13
Guangzhou 12
San Diego 12
Brussels 11
Buffalo 11
Da Nang 11
Florence 11
Hebei 11
São Paulo 11
Changsha 10
Jacksonville 10
Ravenna 10
Frankfurt am Main 9
Jiaxing 9
Mountain View 9
Pune 9
Shanghai 9
Tianjin 9
Haiphong 8
Phoenix 8
The Dalles 8
Fremont 7
Redwood City 7
Xi'an 7
Abidjan 6
Bari 6
Bến Tre 6
Chicago 6
Nanchang 6
Orem 6
San José 6
Torino 6
Toronto 6
Warsaw 6
Abeokuta 5
Atlanta 5
Brooklyn 5
Can Tho 5
Dearborn 5
Johannesburg 5
Kuban 5
Monmouth Junction 5
Mumbai 5
Ninh Bình 5
Norwalk 5
Paris 5
Redondo Beach 5
Rio de Janeiro 5
Taizhou 5
Ardabil 4
Falls Church 4
Lanzhou 4
Managua 4
Ningbo 4
San Francisco 4
Taiyuan 4
Totale 3.181
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 480
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 264
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations 257
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 257
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma 221
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 220
Second-line chemotherapy in patients with biliary tract cancer. 186
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA 175
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 173
Metronomic capecitabine in advanced hepatocellular carcinoma patients:a phase II study. 172
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 170
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. 167
High prevalence of asbestos exposure in bile duct cancer patients 165
The follow-up issues: from the necessity to the opportunity 160
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 158
Second-line chemotherapy in biliary tract cancer patients. 155
Metronomic capecitabine as second-line treatment after sorafenib for hepatocelllular carcinoma. 153
Clinical safety and efficacy of adjuvant chemotherapy in radically resected cholangiocarcinoma patients. 153
High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors 152
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) 150
Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients. 149
Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation 148
Metronomic capecitabine in advanced hepatocellualr cacinoma patients who have failed sorafenib: a phase II study 145
Irinotecan toxicity: genes or intestinal microflora? 140
Metronomic capecitabine as second-line treatment for patients with hepatocellular carcinoma with preserved liver function: A phase II study. 136
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR 131
METRONOMIC CAPECITABINE IN HEPATOCELLULAR CARCINOMA RELAPSE AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY 130
Intestinal microbiota around colorectal cancer genesis 123
Totale 5.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022471 0 0 0 29 54 35 18 35 17 37 144 102
2022/2023750 85 111 39 89 44 54 10 47 114 22 75 60
2023/2024254 27 28 2 22 12 88 16 8 5 11 19 16
2024/2025666 35 88 59 63 156 28 39 33 14 43 19 89
2025/20261.469 159 72 102 109 184 73 120 59 405 122 40 24
2026/2027204 23 46 118 17 0 0 0 0 0 0 0 0
Totale 5.090